NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event
NLS Pharmaceutics Ltd. announces CEO's attendance at BIO-EUROPE Springtime Partnering Event in Barcelona, Spain. The event aims to facilitate one-to-one meetings for over 3,700 attendees from 2,000+ companies.
03/14/2024 - 08:00 AM
ZURICH, SWITZERLAND / ACCESSWIRE / March 14, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that Alex Zwyer, Chief Executive Officer of NLS Pharmaceutics will attend the BIO-EUROPE Springtime Partnering Event, bringing together over 3,700 attendees from 2,000+ companies to engage in 20,000 one-to-one meetings in Barcelona, Spain, taking place March 18-20, 2024.
Please send last minute meeting requests to im@nls-pharma.com
For more information on the conference, visit https://informaconnect.com/bioeurope-spring/
About NLS Pharmaceutics Ltd.
NLS is a global development-stage biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders who have unmet medical needs. Headquartered in Switzerland and founded in 2015, NLS is led by an experienced management team with a track record of developing and commercializing product candidates. For more information, please visit www.nlspharma.com .
For additional information:
Marianne Lambertson (investors & media)
+1 239.682.8500 ml@nls-pharma.com
www.nlspharmaceutics.com
###
SOURCE: NLS Pharmaceutics AG
press release on accesswire.com
NLS Pharmaceutics CEO, Alex Zwyer, is attending the BIO-EUROPE Springtime Partnering Event in Barcelona, Spain.
The event is expected to host over 3,700 attendees from 2,000+ companies.
The event is scheduled to take place from March 18-20, 2024, in Barcelona, Spain.
Meeting requests for the event can be sent to im@nls-pharma.com.
NLSPW Rankings
N/A Ranked by Stock Gains
NLSPW Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major
About NLSPW
mission & values to serve our patients we design affordable, safe and effective therapeutics to safeguard and empower the brain throughout all stages of life. we value partnership and integrity, we are ethical and responsible and show respect and compassion for our patients. r&d strategy the successful companies of tomorrow are those that go beyond delivering products to delivering real solutions and services. r&d is the cornerstone of our company and we promote ingenuity through an effective intellectual property policy. the advancements in science mean that more targeted, more (cost-)effective treatments are within reach and we are here to take on this challenge. our innovative r&d is centered on patients’ needs and delivering affordable, safe and effective solutions. not only will these enable us to improve access to quality healthcare and meet unmet needs, but they will also deliver the sustainable growth required to allow us to continue to invest in innovative research & developm
